| 摘要 |
2119579 9306103 PCTABS00021 Quinoxaline compounds represented by formulas (I) or (II), wherein R1 and R2 are independently hydrogen, C1-6-alkyl, halogen, NO2, NH2, CN, CF3, SO2NR4R5 wherein R4 and R5 are independently hydrogen or C1-6-alkyl, or COR6 wherein R6 is C1-6-alkyl; and R3 is hydrogen, C1-6-alkyl or CF3, compositions thereof and methods of preparing the compounds are described. The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters.
|
